406 related articles for article (PubMed ID: 38212542)
21. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
22. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
24. JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
Gillard L; Pouchot J; Cohen-Aubart F; Koné-Paut I; Mouterde G; Michaud M; Reumaux H; Savey L; Belot A; Fautrel B; Mitrovic S
Rheumatology (Oxford); 2023 Apr; 62(4):1594-1604. PubMed ID: 35920788
[TBL] [Abstract][Full Text] [Related]
25. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
[TBL] [Abstract][Full Text] [Related]
26. Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
Saper VE; Ombrello MJ; Tremoulet AH; Montero-Martin G; Prahalad S; Canna S; Shimizu C; Deutsch G; Tan SY; Remmers EF; Monos D; Hahn T; Phadke OK; Cassidy E; Ferguson I; Mallajosyula V; Xu J; Rosa Duque JS; Chua GT; Ghosh D; Szymanski AM; Rubin D; Burns JC; Tian L; Fernandez-Vina MA; Mellins ED; Hollenbach JA; ;
Ann Rheum Dis; 2022 Mar; 81(3):406-415. PubMed ID: 34789453
[TBL] [Abstract][Full Text] [Related]
27. Tofacitinib-induced remission in refractory adult-onset Still's disease complicated by macrophage activation syndrome.
Honda M; Moriyama M; Kondo M; Kumakura S; Murakawa Y
Scand J Rheumatol; 2020 Jul; 49(4):336-338. PubMed ID: 32329389
[No Abstract] [Full Text] [Related]
28. Complete atrioventricular block and aseptic meningitis in a patient with adult-onset Still's disease and concurrent hemophagocytic syndrome.
Tsuchiya H; Tsuno H; Kaneko S; Yamashita H; Takahashi Y; Kano T; Mimori A
Mod Rheumatol; 2015 Mar; 25(2):332-3. PubMed ID: 24533542
[No Abstract] [Full Text] [Related]
29. Application of MS score in macrophage activation syndrome patients associated with adult onset Still's disease.
Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; Bao C; Fu Q
Ann Rheum Dis; 2021 Sep; 80(9):e145. PubMed ID: 31611222
[No Abstract] [Full Text] [Related]
30. Hemophagocytic syndrome secondary to adult-onset Still's disease but very similar to lymphoma.
Zhang XH; Han YM; Wang WW; Cheng H; Zhu KJ
Int J Clin Exp Pathol; 2012; 5(4):377-81. PubMed ID: 22670185
[TBL] [Abstract][Full Text] [Related]
31. mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome.
Huang Z; You X; Chen L; Du Y; Brodeur K; Jee H; Wang Q; Linder G; Darbousset R; Cunin P; Chang MH; Wactor A; Wauford BM; Todd MJC; Wei K; Li Y; Levescot A; Iwakura Y; Pascual V; Baldwin NE; Quartier P; Li T; Gianatasio MT; Hasserjian RP; Henderson LA; Sykes DB; Mellins ED; Canna SW; Charles JF; Nigrovic PA; Lee PY
Nat Commun; 2022 Nov; 13(1):6915. PubMed ID: 36443301
[TBL] [Abstract][Full Text] [Related]
32. Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.
Segú-Vergés C; Coma M; Kessel C; Smeets S; Foell D; Aldea A
Arthritis Res Ther; 2021 Apr; 23(1):126. PubMed ID: 33892792
[TBL] [Abstract][Full Text] [Related]
33. Adult onset Still's disease with persistent skin lesions complicated by secondary hemophagocytic lymphohistiocytosis.
Sarkar RN; Bhattacharya R; Bhattacharyya K; Paul R; Mullick OS
Int J Rheum Dis; 2014 Jan; 17(1):118-21. PubMed ID: 24119099
[No Abstract] [Full Text] [Related]
34. Hemophagocytic syndrome in adult-onset Still's disease (AOSD): a must for biologics?--Case report and brief review of the literature.
Bürgi U; Mendez A; Hasler P; Hüllstrung HD
Rheumatol Int; 2012 Oct; 32(10):3269-72. PubMed ID: 20383508
[TBL] [Abstract][Full Text] [Related]
35. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
Bindoli S; Galozzi P; Doria A; Sfriso P
Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
[TBL] [Abstract][Full Text] [Related]
36. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
37. Adult-onset Still's disease: Advances in the treatment.
Castañeda S; Blanco R; González-Gay MA
Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
[TBL] [Abstract][Full Text] [Related]
38. A case of adult-onset Still's disease complicated by hemophagocytic syndrome and interstitial pneumonia with pneumomediastinum/recurrent pneumothorax.
Fujii K; Kitamura Y; Osugi Y; Koyama Y; Ota T
Int J Rheum Dis; 2012 Aug; 15(4):e60-2. PubMed ID: 22898226
[No Abstract] [Full Text] [Related]
39. Response to 'Application of MS score in macrophage activation syndrome patients associated with adult onset Still's disease' by Wang
Minoia F; Ravelli A
Ann Rheum Dis; 2021 Sep; 80(9):e146. PubMed ID: 31653650
[No Abstract] [Full Text] [Related]
40. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
